Bulk antibodies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
10
NCT05616208
Implantation of BioSphincter TM for Treatment of Severe Passive Fecal Incontinence
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 2, 2022
Completion: Jul 31, 2027
Loading map...